Your session is about to expire
← Back to Search
Retroperitoneal Lymph Node Dissection for Testicular Seminoma
Study Summary
This trial studies how well a surgery to remove lymph nodes in the retroperitoneum works in treating patients with early-stage testicular seminoma.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- If I had a biopsy, it showed pure seminoma.My recent chest scans show no signs of cancer spread.I do not have any serious illnesses or social situations that would stop me from following the study's requirements.I can carry out all my self-care but cannot do heavy physical work.My blood clotting tests are suitable for surgery, as determined by my surgeon.I have had chemotherapy or radiotherapy in the past.I had imaging of my lymph nodes done within the last 6 weeks.I have 1 to 2 swollen lymph nodes in my abdomen, each less than 3 cm.My lymph node grew to 1.0 cm or more after a borderline CT scan result.I have a type of testicular cancer that has spread to my abdomen lymph nodes or returned there within 3 years.My lymph node swelling is within the surgical area for RPLND.My testicular cancer was removed and confirmed as pure seminoma.I have been diagnosed with more than one type of cancer.
- Group 1: Treatment (RPLND)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How widely dispersed are the facilities conducting this examination within this state?
"There are 14 locations hosting this clinical trial, including the Rutgers Cancer Institute of New jersey in New Brunswick, University of California, San Francisco in San Francisco and Loma Linda University Medical Center in Loma Linda. In addition to these sites, there is a host of other centres available for patient enrolment."
Is there still availability for individuals to enroll in this clinical investigation?
"According to clinicaltrials.gov, this medical investigation is not currently recruiting participants. Initially posted on August 28th 2015 and updated lastly on August 6th 2022, the trial has yet to accept any patients. Nevertheless, there are presently 28 other trials actively searching for volunteers."
Share this study with friends
Copy Link
Messenger